Clinical Trial Update: A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED) [Phase 2]

View source ↗

Summary

Completed Phase 2 trial comparing Indinavir plus Ritonavir plus two NRTIs versus Nelfinavir plus two NRTIs in HIV-positive patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Indinavir (indinavir)
• NRTIs (two unspecified)
• Nelfinavir (nelfinavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections | Phase 2 | Status: COMPLETED